New Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has sought major revisions in the Phase III clinical trial protocol submitted by ...

This project is under active development. For the version of Plasmid ID associated with the manuscript "Adaptation of Plasmid-ID Technology for Evaluation of N2-Fixing Effectiveness and ...

Forbes contributors publish independent expert analyses and insights. Scott Hutcheson teaches leadership at Purdue University. Faced with a crowded dining room and dwindling supplies, Cardini ...

- EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of ...

- EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing ...

Citing cost increases and fraud in the program, state Sen. George Borrello and several members of the Senate Republican Conference call on Gov. Kathy ...

- EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of ...

From cosmetics to dietary supplements to regenerative medicine, the global market for collagen — and increasingly, vegan and/or plant-based collagen products — has expanded dramatically in recent ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

Introduction Intracerebral haemorrhage (ICH) stands as a leading global cause of death and disability, posing a significant challenge with limited treatment options, especially for chronic patients.